A Pharmacokinetic Evaluation Study in Healthy Volunteers
NCT00210093
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
denufosol tetrasodium (INS37217)
Sponsor
Merck Sharp & Dohme LLC